Gene · 1870
Papers2,847
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,847
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Platycodin-D exerts its anti-cancer effect by promoting c-Myc protein ubiquitination and degradation in gastric cancer. | Front Pharmacol | 2023 | 36950011 | PubTator, text mining | PubMed |
| A new method to synthesize multiple gRNA libraries and functional mapping of mammalian H3K4me3 regions. | Nucleic Acids Res | 2023 | 36938898 | PubTator, text mining | PubMed |
| The molecular basis of p21-activated kinase-associated neurodevelopmental disorders: From genotype to phenotype. | Front Neurosci | 2023 | 36937657 | PubTator, text mining | PubMed |
| Comprehensive analysis of autophagy-related clusters and individual risk model for immunotherapy response prediction in gastric cancer. | Front Oncol | 2023 | 36937439 | PubTator, text mining | PubMed |
| Associating brain imaging phenotypes and genetic risk factors via a hypergraph based netNMF method. | Front Aging Neurosci | 2023 | 36936501 | PubTator, text mining | PubMed |
| RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis. | J Clin Invest | 2023 | 36928314 | PubTator, text mining | PubMed |
| Comprehensive Analysis Based on the Cancer Immunotherapy and Immune Activation of Gastric Cancer Patients. | Genet Res (Camb) | 2023 | 36923953 | PubTator, text mining | PubMed |
| Recent advances in the functional explorations of nuclear microRNAs. | Front Immunol | 2023 | 36911728 | PubTator, text mining | PubMed |
| Current Trends in Mucosal Melanomas: An Overview. | Cancers (Basel) | 2023 | 36900152 | PubTator, text mining | PubMed |
| E2F2 Promotes Wound Healing of Diabetic Foot Ulcer by Regulating CDCA7L Transcription. | Exp Clin Endocrinol Diabetes | 2023 | 36893788 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| LncRNA and its role in gastric cancer immunotherapy. | Front Cell Dev Biol | 2023 | 36875764 | PubTator, text mining | PubMed |
| Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. | Ther Adv Med Oncol | 2023 | 36872946 | PubTator, text mining | PubMed |
| Multiomics analysis revealed the mechanisms related to the enhancement of proliferation, metastasis and EGFR-TKI resistance in EGFR-mutant LUAD with ARID1A deficiency. | Cell Commun Signal | 2023 | 36869329 | PubTator, text mining | PubMed |
| An Integrated Approach of Learning Genetic Networks From Genome-Wide Gene Expression Data Using Gaussian Graphical Model and Monte Carlo Method. | Bioinform Biol Insights | 2023 | 36865982 | PubTator, text mining | PubMed |
| Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy. | Appl Biochem Biotechnol | 2023 | 36864364 | PubTator, text mining | PubMed |
| Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer. | Cancer Discov | 2023 | 36862804 | PubTator, text mining | PubMed |
| RNA-seq reveals novel mechanistic targets of Livin in bladder cancer. | BMC Urol | 2023 | 36855119 | PubTator, text mining | PubMed |
| Roles of E2F family members in the diagnosis and prognosis of head and neck squamous cell carcinoma. | BMC Med Genomics | 2023 | 36855110 | PubTator, text mining | PubMed |
| Three-dimensional growth reveals fine-tuning of 5-lipoxygenase by proliferative pathways in cancer. | Life Sci Alliance | 2023 | 36849252 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1870/papers?page=16